Aspen Makes Another $1B Growth Play With New Merck Deal
Generic-drug maker Aspen Pharmacare Holdings Ltd. will put up about $1 billion for a Merck & Co. Inc. pharmaceutical manufacturing unit and a product portfolio, it said Thursday, marking its second...To view the full article, register now.
Already a subscriber? Click here to view full article